このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

自然環境における神経発達障害のある子供に対する EXPLORER 外骨格の有効性と使用性

2026年11月13日 更新者:MarsiBionics

Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. EXPLORER is a robotic gait exoskeleton designed to rehabilitate children with motor disabilities in home and outdoor environments.

The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.

調査の概要

状態

完了

詳細な説明

Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.

An initial session will be conducted in the participant's natural environment, during which the researchers will instruct the primary caregivers on the use of the device. Subsequently, the device will be left for a two-month period for use in the natural settings deemed appropriate by the family.

研究の種類

介入

入学 (実際)

20

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Madrid
      • Alcorcón、Madrid、スペイン、28922
        • Universidad Rey Juan Carlos
      • Madrid、Madrid、スペイン、28046
        • Hospital Universitario La Paz
      • Madrid、Madrid、スペイン、28009
        • Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia
      • Madrid、Madrid、スペイン、28007
        • Hospital Universitario Gregorio Marañón
      • Madrid、Madrid、スペイン、28009
        • Hospital Infantil Universitario Niño Jesús - Servicio de Rehabilitación
      • Madrid、Madrid、スペイン、28041
        • Hospital Universitario 12 Octubre

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

2年~17年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Diagnosis of any pathology or condition causing neurodevelopmental disorders.
  • Ability to continuously use the device for two weeks, at least 3 times per week, without causing excessive fatigue that would prevent the participant from carrying out their usual activities.
  • Availability and commitment from the family to use the device at least 3 times per week during the planned period, in different environments and with various objectives.
  • Medical authorization for standing, gait training and weight bearing.
  • Informed consent signed by legal guardians.
  • Maximum user weight of 60 kg.
  • Hip width (between greater trochanters) ≤37 cm.
  • Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 21cm to 36cm.
  • Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 20cm to 35cm.
  • Shoe size ≤40 (EU)

Exclusion Criteria:

  • Medical contraindications for standing or walking.
  • Non-reducible contractures or heterotropic ossifications above the degrees allowed by the device or out of the trajectory imposed by the device
  • Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
  • More than 20º of hip and/or knee non-reducible contractures at the time of using the exoskeleton.
  • Necessity to walk with more than 5º of hip abduction.
  • Impossibility to reach 5º of ankle dorsiflexion with ir without orthoses.
  • Lower length dysmetria that cannot be mitigated with a wedge under the foot.
  • Skin lesion on parts of the lower extremities that are in contact with the device.
  • History of fracture without trauma.
  • Presence of other conditions causing exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, severe pulmonary disease).
  • Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness.
  • Allergy to any of the EXPLORER materials: cotton, nylon, polyester, PPS, PEEK or ABS.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:EXPLORER

Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.

Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Serious Adverse Events
時間枠:through study completion, along 2 weeks

occurrence of any serious adverse event to the participant or the caregiver

through study completion, along 2 weeks
Falls prevalence
時間枠:through study completion, along 2 weeks

Number of falling events occurred from the participant or caregiver

through study completion, along 2 weeks
Skin integrity
時間枠:through study completion, along 2 weeks

Occurrence of any injury of the skin in the areas of contact and produced by the use of the device

through study completion, along 2 weeks
Pain (Visual Analogic Scale)
時間枠:through study completion, along 2 weeks

pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain"

through study completion, along 2 weeks
Donning and doffing time
時間枠:through study completion, along 2 weeks

Time to don and doff the device to each participant

through study completion, along 2 weeks
Device usage time
時間枠:through study completion, along 2 weeks

Time using the device

through study completion, along 2 weeks
Number of steps
時間枠:through study completion, along 2 weeks

number of steps with the device

through study completion, along 2 weeks
Usage modes
時間枠:through study completion, along 2 weeks

two different usage modes (active and automatic).

through study completion, along 2 weeks
Speed
時間枠:through study completion, along 2 weeks

speed achieved with the device (steps per minute)

through study completion, along 2 weeks
Device accessibility
時間枠:through study completion, along 2 weeks

Environments where the device has been used and level of accessibility in each environment measured with a 5 points Likert scale (0 not accessible - 5 very accessible)

through study completion, along 2 weeks
Range of motion
時間枠:Before starting the intervention (S1) and after completing the two weeks of use

Passive Degree to which a joint can move (hip, knee, and ankle joints in both legs). From 0º to 180º.

Before starting the intervention (S1) and after completing the two weeks of use
Participation
時間枠:Before starting the intervention (S1) and after completing the two weeks of use

Measured with the Child and Adolescent Scale of Participation. 20 ordinal scaled items across 4 subsections.

Maximum total score is 80 (20 items x 4) and the minimum total score is 20 (20 items x 1)

Before starting the intervention (S1) and after completing the two weeks of use

二次結果の測定

結果測定
メジャーの説明
時間枠
QUEST
時間枠:at the end of the intervention

Using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire administered to the participants' caregivers at the end of the intervention. The QUEST 2.0 scale has 12 items. Each item is rated on a 5-point Likert scale

at the end of the intervention

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年3月1日

一次修了 (実際)

2026年8月1日

研究の完了 (実際)

2026年9月1日

試験登録日

最初に提出

2024年12月20日

QC基準を満たした最初の提出物

2025年1月2日

最初の投稿 (実際)

2025年1月9日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月16日

QC基準を満たした最後の更新が送信されました

2026年11月13日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する